D. Michael Evans

403 total citations
9 papers, 340 citations indexed

About

D. Michael Evans is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, D. Michael Evans has authored 9 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in D. Michael Evans's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Peptidase Inhibition and Analysis (3 papers) and HIV Research and Treatment (2 papers). D. Michael Evans is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Peptidase Inhibition and Analysis (3 papers) and HIV Research and Treatment (2 papers). D. Michael Evans collaborates with scholars based in United States, Switzerland and United Kingdom. D. Michael Evans's co-authors include Michel L. Aubert, R. Haigh, Doreen M. Ashworth, Pierre Broqua, Richard White, Jean‐Louis Junien, Julie Chao, William C. De Wolf, Lee Chao and Sharma Sk and has published in prestigious journals such as Diabetes, American Journal Of Pathology and Tetrahedron.

In The Last Decade

D. Michael Evans

9 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Michael Evans United States	6	136	125	114	81	68	9	340
Gennady Gololobov United States	11	162 1.2×	23 0.2×	213 1.9×	22 0.3×	41 0.6×	12	575
S. Reuse Belgium	11	115 0.8×	82 0.7×	153 1.3×	9 0.1×	18 0.3×	14	304
Yannick Waumans Belgium	7	104 0.8×	234 1.9×	134 1.2×	12 0.1×	42 0.6×	11	365
Alice Barbarin France	9	10 0.1×	66 0.5×	132 1.2×	31 0.4×	30 0.4×	17	372
Terrence Grady United States	9	44 0.3×	226 1.8×	173 1.5×	5 0.1×	415 6.1×	14	586
Zineb Mounir Canada	10	15 0.1×	87 0.7×	380 3.3×	18 0.2×	30 0.4×	22	582
Victoria Luchenko United States	10	28 0.2×	153 1.2×	372 3.3×	10 0.1×	9 0.1×	13	483
Geneviève St‐Onge Canada	7	26 0.2×	184 1.5×	222 1.9×	6 0.1×	42 0.6×	9	446
Rashi Kalra India	12	12 0.1×	76 0.6×	146 1.3×	24 0.3×	18 0.3×	24	379
Arja Reinikainen Finland	5	34 0.3×	91 0.7×	145 1.3×	26 0.3×	13 0.2×	6	405

Countries citing papers authored by D. Michael Evans

Since Specialization

Citations

This map shows the geographic impact of D. Michael Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Michael Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Michael Evans more than expected).

Fields of papers citing papers by D. Michael Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Michael Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Michael Evans. The network helps show where D. Michael Evans may publish in the future.

Co-authorship network of co-authors of D. Michael Evans

This figure shows the co-authorship network connecting the top 25 collaborators of D. Michael Evans. A scholar is included among the top collaborators of D. Michael Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Michael Evans. D. Michael Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Clermont, Allen C., Nivetha Murugesan, Qunfang Zhou, et al.. (2016). Plasma Kallikrein Mediates Vascular Endothelial Growth Factor–Induced Retinal Dysfunction and Thickening. Investigative Ophthalmology & Visual Science. 57(6). 2390–2390. 26 indexed citations

Yoon, Hyesook, Sachiko I. Blaber, D. Michael Evans, et al.. (2008). Activation profiles of human kallikrein‐related peptidases by proteases of the thrombostasis axis. Protein Science. 17(11). 1998–2007. 37 indexed citations

Willand, Nicolas, et al.. (2002). Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV inhibitor NVP-DPP728. Tetrahedron. 58(28). 5741–5746. 5 indexed citations

Broqua, Pierre, Richard White, Doreen M. Ashworth, et al.. (2002). Chronic Inhibition of Circulating Dipeptidyl Peptidase IV by FE 999011 Delays the Occurrence of Diabetes in Male Zucker Diabetic Fatty Rats. Diabetes. 51(5). 1461–1469. 148 indexed citations

Wolf, William C. De, D. Michael Evans, Lee Chao, & Julie Chao. (2001). A Synthetic Tissue Kallikrein Inhibitor Suppresses Cancer Cell Invasiveness. American Journal Of Pathology. 159(5). 1797–1805. 52 indexed citations

Evans, D. Michael. (2000). Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients. 4(3). 72–72. 2 indexed citations

Evans, D. Michael, et al.. (1993). Inhibition of the RNA‐directed DNA polymerase activity of a recombinant HIV‐1 p51 reverse transcriptase by a p15 ribonuclease H domain. Biotechnology and Applied Biochemistry. 17(1). 91–102. 2 indexed citations

Sk, Sharma, et al.. (1991). Metal affinity chromatography of recombinant HIV‐1 reverse transcriptase containing a human renin cleavable metal binding domain. Biotechnology and Applied Biochemistry. 14(1). 69–81. 52 indexed citations

Evans, D. Michael, et al.. (1990). Substrate specificity and inhibitor structure‐activity relationships of recombinant human renin: implications in the in vivo evaluation of renin inhibitors. Biotechnology and Applied Biochemistry. 12(2). 161–175. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact